journal article·2026-05Open access

β‐Triketone‐Based Ionizable Cationic Lipids Synthesized via Click Chemistry for siRNA Delivery

Huatian Li, Haocheng Tang, Yiqing Mu, Shangyu Chen, Paul Edward Floreancig, Junmei Wang, Yixian Huang, Song Li

Advanced Science· Volume 13· Issue 26

Abstract

ABSTRACT Lipid nanoparticles (LNPs) have demonstrated their effectiveness as carriers for the delivery of RNA therapeutics. As the core components of the LNP system, ionizable cationic lipids (ICLs) are still the major focus of research in this field. In this study, we reported a class of novel β‐triketone‐based ICLs synthesized via click chemistry. We demonstrated that the reaction could be completed instantaneously, and a library of ICLs was generated in a short time. In vitro and in vivo screening identified a lipid that was comparable to FDA approved Dlin‐MC3‐DMA lipid in siRNA LNPs‐mediated gene silencing. In addition, we adopted a computational approach to characterizing the click chemistry in lipid synthesis, as well as the binding between siRNA and ICLs. Our work offers a novel approach to synthesizing ICLs of new structural features, which may not only improve our understanding of the structure‐activity relationship (SAR) of ICLs but also lead to the development of improved LNPs for more effective delivery of nucleic acid therapeutics.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced Polymer Synthesis and Characterization · Polydiacetylene-based materials and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Center for Pharmacogenetics Department of Pharmaceutical Sciences School of Pharmacy University of Pittsburgh Pittsburgh Pennsylvania USA

Computational Chemical Genomics Screening Center Department of Pharmaceutical Sciences School of Pharmacy University of Pittsburgh Pittsburgh Pennsylvania USA

Department of Chemistry Dietrich School of Arts and Sciences University of Pittsburgh Pittsburgh Pennsylvania USA

Funding

National Institutes of Health

References (56)

Show source-provided references
1. 10.1371/journal.pbio.300210510.1371/journal.pbio.3002105 ↗
2. 10.1016/j.jconrel.2019.01.00110.1016/j.jconrel.2019.01.001 ↗
3. 10.1016/j.addr.2024.11544610.1016/j.addr.2024.115446 ↗
4. 10.1038/s41573‐024‐00977‐610.1038/s41573‐024‐00977‐6 ↗
5. 10.1002/smll.20220696810.1002/smll.202206968 ↗
6. 10.1002/anie.20200808210.1002/anie.202008082 ↗
7. 10.1021/jacs.4c0045110.1021/jacs.4c00451 ↗
8. 10.1021/acs.nanolett.9b0424610.1021/acs.nanolett.9b04246 ↗
9. 10.1016/j.apsb.2022.04.01310.1016/j.apsb.2022.04.013 ↗
10. 10.1038/s41557‐019‐0249‐210.1038/s41557‐019‐0249‐2 ↗
11. 10.1021/acscentsci.3c0109610.1021/acscentsci.3c01096 ↗
12. 10.1038/s41893‐023‐01160‐210.1038/s41893‐023‐01160‐2 ↗
13. 10.1021/acs.accounts.2c0030810.1021/acs.accounts.2c00308 ↗
14. 10.1002/1521‐3773(20010601)40:11<2004::AID‐ANIE2004>3.0.CO;2‐510.1002/1521‐3773(20010601)40:11<2004::AID‐ANIE2004>3.0.CO;2‐5 ↗
15. 10.1021/acs.accounts.1c0054410.1021/acs.accounts.1c00544 ↗
16. 10.1021/np980350n10.1021/np980350n ↗
17. 10.1021/jacs.4c0466410.1021/jacs.4c04664 ↗
18. 10.1021/ja00864a03110.1021/ja00864a031 ↗
19. 10.1021/jp711191j10.1021/jp711191j ↗
20. 10.1146/annurev‐chembioeng‐062011‐08110810.1146/annurev‐chembioeng‐062011‐081108 ↗
21. 10.1055/s-2007-96592410.1055/s-2007-965924 ↗
22. 10.1016/j.onano.2023.10016110.1016/j.onano.2023.100161 ↗
23. 10.1021/acsnano.4c1462510.1021/acsnano.4c14625 ↗
24. 10.1038/nbt.160210.1038/nbt.1602 ↗
25. 10.1021/acs.molpharmaceut.2c0003310.1021/acs.molpharmaceut.2c00033 ↗
26. 10.1007/s11095‐022‐03460‐210.1007/s11095‐022‐03460‐2 ↗
27. 10.1002/anie.20201392710.1002/anie.202013927 ↗
28. 10.1016/j.ab.2016.07.02210.1016/j.ab.2016.07.022 ↗
29. 10.1038/s41467‐023‐39768‐910.1038/s41467‐023‐39768‐9 ↗
30. 10.1073/pnas.210925611810.1073/pnas.2109256118 ↗
31. 10.1038/s41467‐025‐63726‐210.1038/s41467‐025‐63726‐2 ↗
32. 10.1002/smtd.20240186010.1002/smtd.202401860 ↗
33. 10.1016/j.omtm.2025.10143610.1016/j.omtm.2025.101436 ↗
34. 10.1186/s12951‐024‐02972‐w10.1186/s12951‐024‐02972‐w ↗
35. 10.1038/s41467‐025‐60959‐z10.1038/s41467‐025‐60959‐z ↗
36. 10.1016/j.jconrel.2025.02.05510.1016/j.jconrel.2025.02.055 ↗
37. 10.1038/s41467‐024‐50093‐710.1038/s41467‐024‐50093‐7 ↗
38. 10.1002/jcc.2029010.1002/jcc.20290 ↗
39. 10.1021/acsomega.9b0423310.1021/acsomega.9b04233 ↗
40. 10.1021/ci100275a10.1021/ci100275a ↗
41. 10.1021/acs.jctc.3c0004410.1021/acs.jctc.3c00044 ↗
42. 10.1021/jacs.4c1026510.1021/jacs.4c10265 ↗
43. 10.1002/anie.20241538910.1002/anie.202415389 ↗
44. 10.1038/s41557‐024‐01557‐210.1038/s41557‐024‐01557‐2 ↗
45. 10.1021/acsnano.0c0263310.1021/acsnano.0c02633 ↗
46. 10.1038/s41467-022-35637-z10.1038/s41467-022-35637-z ↗
47. 10.1038/s41467‐021‐27493‐010.1038/s41467‐021‐27493‐0 ↗
48. 10.1002/adma.20210170710.1002/adma.202101707 ↗
49. 10.1016/j.mtadv.2022.10029510.1016/j.mtadv.2022.100295 ↗
50. 10.1021/ja010534f10.1021/ja010534f ↗
51. 10.1016/j.cplett.2006.12.05510.1016/j.cplett.2006.12.055 ↗
52. 10.1021/jp205508z10.1021/jp205508z ↗
53. 10.1021/jp107136j10.1021/jp107136j ↗
54. 10.1021/jp063552y10.1021/jp063552y ↗
55. Jonathan Z. O. · 2025
56. 10.1126/science.abj875410.1126/science.abj8754 ↗